Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Monte Rosa Therapeutics (GLUE) vs. Competitors

408 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GLUEMonte Rosa Therapeutics$8.91$761.36M-5.21-36.99%Strong BuyUnlock the GLUE analyst price target with TipRanks PremiumGLUEUnlock the GLUE top-analyst price target with TipRanks Premium
KURAKura Oncology$7.35$675.31M-2.23-35.07%Strong BuyUnlock the KURA analyst price target with TipRanks PremiumGLUE vs KURAUnlock the KURA top-analyst price target with TipRanks Premium
ARVNArvinas Holding Company$6.74$441.37M-44.93-41.54%Moderate BuyUnlock the ARVN analyst price target with TipRanks PremiumGLUE vs ARVNUnlock the ARVN top-analyst price target with TipRanks Premium
CCCCC4 Therapeutics$2.44$320.41M-3.39-2.40%Strong BuyUnlock the CCCC analyst price target with TipRanks PremiumGLUE vs CCCCUnlock the CCCC top-analyst price target with TipRanks Premium
ALMSAlumis Inc.$4.33$562.12M-1.25-34.09%Strong BuyUnlock the ALMS analyst price target with TipRanks PremiumGLUE vs ALMSUnlock the ALMS top-analyst price target with TipRanks Premium
ODTXOdyssey Therapeutics, Inc.$18.34$881.56M-4.9411.69%Strong BuyUnlock the ODTX analyst price target with TipRanks PremiumGLUE vs ODTXUnlock the ODTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GLUEMonte Rosa Therapeutics8.91-4.61-34.10%
KURAKura Oncology7.35-3.63-33.06%
ARVNArvinas Holding Company6.74-4.28-38.84%
CCCCC4 Therapeutics2.440.062.52%
ALMSAlumis Inc.4.33-2.59-37.43%
ODTXOdyssey Therapeutics, Inc.18.341.9211.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts